Variant report
Variant | esv2764034 |
---|---|
Chromosome Location | chr7:86227204-86245054 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:86227396..86228184-chr7:86533852..86535050,3 | MCF-7 | breast: | |
2 | chr7:86229843..86230499-chr7:86534273..86535119,3 | MCF-7 | breast: | |
3 | chr7:86227683..86228333-chr7:86444044..86444945,4 | MCF-7 | breast: | |
4 | chr7:86226974..86228267-chr7:86444166..86444792,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2102384 | chr7:86229602-86229603 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs144659512 | chr7:86229670-86229671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542559093 | chr7:86229673-86229674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560734819 | chr7:86229679-86229680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566723938 | chr7:86229714-86229715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75570178 | chr7:86229758-86229759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564951103 | chr7:86229764-86229765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538879433 | chr7:86229773-86229774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532117171 | chr7:86229785-86229786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550542118 | chr7:86229878-86229879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562392379 | chr7:86229892-86229893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530396542 | chr7:86229936-86229937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577640733 | chr7:86229969-86229970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538767393 | chr7:86229973-86229974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs73704567 | chr7:86229988-86229989 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs567186071 | chr7:86230027-86230028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185384730 | chr7:86230049-86230050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556790190 | chr7:86230071-86230072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190280695 | chr7:86230074-86230075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371588117 | chr7:86230130-86230131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112985977 | chr7:86230206-86230207 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570881070 | chr7:86230212-86230213 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537993362 | chr7:86230216-86230217 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141418169 | chr7:86230223-86230224 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568398504 | chr7:86230240-86230241 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535473948 | chr7:86230258-86230259 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554417312 | chr7:86230276-86230277 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150837947 | chr7:86230333-86230334 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572807770 | chr7:86230369-86230370 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10241183 | chr7:86230375-86230376 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs139852682 | chr7:86230378-86230379 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576870238 | chr7:86230467-86230468 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544004124 | chr7:86230473-86230474 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561134382 | chr7:86230529-86230530 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181574704 | chr7:86230606-86230607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541868325 | chr7:86230642-86230643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185885483 | chr7:86230667-86230668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527996992 | chr7:86230675-86230676 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552726141 | chr7:86230720-86230721 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571001298 | chr7:86230727-86230728 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531807611 | chr7:86230793-86230794 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573211999 | chr7:86230827-86230828 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1084096 | chr7:86230839-86230840 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs565325855 | chr7:86230873-86230874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568564275 | chr7:86230917-86230918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145475317 | chr7:86230977-86230978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553761704 | chr7:86231047-86231048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532488861 | chr7:86231049-86231050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566420854 | chr7:86231156-86231157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147264043 | chr7:86231167-86231168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 19318497 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:86229600-86230800 | Enhancers | Brain Hippocampus Middle | brain |
2 | chr7:86229800-86230600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr7:86230000-86230200 | Enhancers | Brain Substantia Nigra | brain |
4 | chr7:86230000-86230400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr7:86230000-86230800 | Enhancers | Brain Anterior Caudate | brain |
6 | chr7:86230000-86230800 | Enhancers | Brain Inferior Temporal Lobe | brain |
7 | chr7:86230200-86230600 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr7:86230200-86230600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr7:86230200-86230600 | Flanking Active TSS | Brain Substantia Nigra | brain |
10 | chr7:86230200-86231000 | Enhancers | Brain Angular Gyrus | brain |
11 | chr7:86230200-86231600 | Enhancers | Brain Cingulate Gyrus | brain |
12 | chr7:86230400-86230800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr7:86230400-86231000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr7:86230600-86230800 | Enhancers | Brain Substantia Nigra | brain |
15 | chr7:86230600-86231600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr7:86231000-86232000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
17 | chr7:86231000-86235000 | Weak transcription | Brain Angular Gyrus | brain |
18 | chr7:86231600-86231800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr7:86232000-86232200 | Enhancers | HUES48 Cell Line | embryonic stem cell |